HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression. [electronic resource]
Producer: 20191021Description: 7226-7234 p. digitalISSN:- 1097-4644
- Analysis of Variance
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- China
- Down-Regulation
- Doxorubicin -- therapeutic use
- Drug Resistance, Neoplasm
- Ectopic Gene Expression
- Gene Expression Regulation, Neoplastic
- Hospitals, University
- Humans
- MicroRNAs -- antagonists & inhibitors
- Molecular Mimicry
- Neoplasm Staging
- Paclitaxel -- therapeutic use
- RNA, Long Noncoding -- genetics
- S Phase
- Stomach Neoplasms -- drug therapy
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.